血栓通、维脑路通经颈动脉给药治疗脑梗塞58例临床观察  

Clinical observation on treating 58 cases of cerebral infarction through carotid artery to give Xueshuantong and venoruton

作　　者：李统干 黄彩森 冯萍 

机构地区：[1]广西玉林市容县中医院,广西容县537500

出　　处：《中医临床研究》2012年第22期52-53,共2页Clinical Journal Of Chinese Medicine

摘　　要：目的:探究应用血栓通、维脑路通经颈动脉给药治疗急性脑梗塞的临床疗效。方法:将我科于2012年1月1日～2012年7月30日收治的116例脑梗塞患者分为对照组和治疗组,每组58人。对照组给予西医常规疗法加静脉应用血栓通、维脑路通,治疗组在西医常规疗法的基础上经颈动脉给予血栓通、维脑路治疗,观察对比分析两组的疗效。结果:治疗组疗效显著优于对照组(P<0.05),且无明显不良反应。讨论:血栓通、维脑路通经颈动脉给药治疗脑梗塞临床疗效显著,有利于提高患者生活质量,安全可靠,值得临床推广应用。Objective：To explore the clinical effects of carotid artery dosing in treating acute cerebral infarction.Methods：Our department admitted from January 1,2012 to 2012,July 30,116 cases were divided into the control group and the treatment group,58 people in each group.The control group received the modern conventional therapy plus the intravenous application of Xueshuantong and venoruton,the treatment group was treated through carotid artery to give Xueshuantong and venoruton on the base of treatment of the control group,the efficacy of the two groups were observed,compared and analyzed.Results：The efficacy of the treatment group was significantly better than that of the control group（P0.05）,and no significant adverse reactions.Discussion：Through carotid artery to give Xueshuantong and venoruton was effective in treating cerebral infarction,could improve the quality of life,and was safe and reliable,worthy of clinical application.

关 键 词：血栓通 维脑路通 颈动脉给药 脑梗塞 

分 类 号：R743.33[医药卫生—神经病学与精神病学]